Raf Roelands
Direktor/Vorstandsmitglied bei MRM Health NV
Profil
Raf Roelands is currently a Director at Ontoforce NV, a Director at MRM Health NV, a Director at Hypervision Surgical Ltd., and an Investment Manager at Korys Management NV.
He was formerly a Director at reMYND NV.
Aktive Positionen von Raf Roelands
Unternehmen | Position | Beginn |
---|---|---|
Korys Management NV
Korys Management NV Investment ManagersFinance Korys Management NV is a Private Equity/Venture Capital firm, a subsidiary of Korys NV founded in 2000. Korys Management NV is headquartered in Halle. | Private Equity Investor | 01.06.2019 |
Ontoforce NV
Ontoforce NV Packaged SoftwareTechnology Services Ontoforce NV creates and implements pioneering technology for information flow and management. Its disQover connects internal and private data with external and public information. The company was founded by Hans Simon Constandt in 2011 and is headquartered in Ghent, Belgium. | Direktor/Vorstandsmitglied | - |
MRM Health NV
MRM Health NV BiotechnologyHealth Technology MRM Health NV is a biopharmaceutical company, which engages in the discovery and development of therapeutics based on the human microbiome. It offers Simulator of the Human Intestinal Microbial Ecosystem (SHIME), allowing to model the complete intestine and its microbiome in the lab, in both health and disease. The company was founded by Sam Possemiers and is headquartered in Ghent, Belgium. | Direktor/Vorstandsmitglied | 01.02.2020 |
Hypervision Surgical Ltd.
Hypervision Surgical Ltd. Packaged SoftwareTechnology Services Hypervision Surgical Ltd. is a British company that aims to improve the precision, safety, and speed of surgeries. The company achieves this by using AI-powered hyperspectral imaging to guide the future of surgery. The company was founded by Sebastien Ourselin, Jonathan Shapey, Tom Vercauteren, and Michael Ebner. Michael Ebner has been the CEO since incorporation. | Direktor/Vorstandsmitglied | 01.06.2023 |
Ehemalige bekannte Positionen von Raf Roelands
Unternehmen | Position | Ende |
---|---|---|
reMYND NV
reMYND NV Miscellaneous Commercial ServicesCommercial Services reMYND NV engages in the development of disease-modifying treatments against alzheimer's, parkinson's, diabetes and other protein misfolding disorders. Its drug and development unit focuses on innovative, disease-modifying drugs for treating degenerative disorders. The company was founded by Fred Van Leuven, Stefaan Wera and Joris Winderickx in 2002 and is headquartered in Leuven, Belgium. | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 5 |
---|---|
Korys Management NV
Korys Management NV Investment ManagersFinance Korys Management NV is a Private Equity/Venture Capital firm, a subsidiary of Korys NV founded in 2000. Korys Management NV is headquartered in Halle. | Finance |
Ontoforce NV
Ontoforce NV Packaged SoftwareTechnology Services Ontoforce NV creates and implements pioneering technology for information flow and management. Its disQover connects internal and private data with external and public information. The company was founded by Hans Simon Constandt in 2011 and is headquartered in Ghent, Belgium. | Technology Services |
MRM Health NV
MRM Health NV BiotechnologyHealth Technology MRM Health NV is a biopharmaceutical company, which engages in the discovery and development of therapeutics based on the human microbiome. It offers Simulator of the Human Intestinal Microbial Ecosystem (SHIME), allowing to model the complete intestine and its microbiome in the lab, in both health and disease. The company was founded by Sam Possemiers and is headquartered in Ghent, Belgium. | Health Technology |
reMYND NV
reMYND NV Miscellaneous Commercial ServicesCommercial Services reMYND NV engages in the development of disease-modifying treatments against alzheimer's, parkinson's, diabetes and other protein misfolding disorders. Its drug and development unit focuses on innovative, disease-modifying drugs for treating degenerative disorders. The company was founded by Fred Van Leuven, Stefaan Wera and Joris Winderickx in 2002 and is headquartered in Leuven, Belgium. | Commercial Services |
Hypervision Surgical Ltd.
Hypervision Surgical Ltd. Packaged SoftwareTechnology Services Hypervision Surgical Ltd. is a British company that aims to improve the precision, safety, and speed of surgeries. The company achieves this by using AI-powered hyperspectral imaging to guide the future of surgery. The company was founded by Sebastien Ourselin, Jonathan Shapey, Tom Vercauteren, and Michael Ebner. Michael Ebner has been the CEO since incorporation. | Technology Services |